摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methyl-N-{1-[(1-methyl-1H-indazol-3-yl)methyl]-4-piperidinyl}-3,5-bis(methyloxy)benzamide | 1206885-44-0

中文名称
——
中文别名
——
英文名称
4-methyl-N-{1-[(1-methyl-1H-indazol-3-yl)methyl]-4-piperidinyl}-3,5-bis(methyloxy)benzamide
英文别名
3,5-dimethoxy-4-methyl-N-[1-[(1-methylindazol-3-yl)methyl]piperidin-4-yl]benzamide
4-methyl-N-{1-[(1-methyl-1H-indazol-3-yl)methyl]-4-piperidinyl}-3,5-bis(methyloxy)benzamide化学式
CAS
1206885-44-0
化学式
C24H30N4O3
mdl
——
分子量
422.527
InChiKey
NOSYEHOSYLYNKR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    31
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    68.6
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • (5-MEMBERED)-(5-MEMBERED) OR (5-MEMBERED)-(6-MEMBERED) FUSED RING CYCLOALKYLAMINE DERIVATIVE
    申请人:MSD K.K.
    公开号:EP2319841A1
    公开(公告)日:2011-05-11
    Disclosed are a compound of a formula (I) and its pharmaceutically-acceptable salt: wherein Q is CH or N; R1a, R1b, R1c and R1d are independently a C1-6 alkyl, a halo-C1-6 alkyl, etc.; R2 is a hydrogen atom, etc.; R3 is independently a hydrogen atom, a C1-6 alkyl, etc., or two R3'S, taken together, form a bridge such as methylene, etc.; R4 and R4b are independently a hydrogen atom, a C1-6 alkyl, etc.; Z is a bicyclic aromatic hetero ring, etc.; Ar is a benzene ring, etc.; m1 and m2 are independently 0, 1 or 2; n is an integer of from 1 to 4. The compound and its salt act as a melanin concentrating hormone receptor antagonist, and are useful as a preventive or remedy for central system disorders, cardiovascular disorders, metabolic disorders, etc.
    本发明公开了一种具有化学式(I)及其药用可接受盐的化合物:其中Q为CH或N;R1a、R1b、R1c和R1d独立地为C1-6烷基、卤代C1-6烷基等;R2为氢原子等;R3独立地为氢原子、C1-6烷基等,或两个R3'结合在一起形成例如亚甲基等的桥;R4和R4b独立地为氢原子、C1-6烷基等;Z为双环芳香杂环、等;Ar为苯环等;m1和m2独立地为0、1或2;n为1至4的整数。该化合物及其盐作为黑色素浓集激素受体拮抗剂,并且可用作中枢系统紊乱、心血管紊乱、代谢紊乱等的预防或治疗。
  • 5/5-OR 5/6-MEMBERED CONDENSED RING CYCLOALKYLAMINE DERIVATIVE
    申请人:Kishino Hiroyuki
    公开号:US20110124674A1
    公开(公告)日:2011-05-26
    Disclosed are a compound of a formula (I) and its pharmaceutically-acceptable salt: wherein Q is CH or N; R 1a , R 1b , R 1c and R 1d are independently a C 1-6 alkyl, a halo-C 1-6 alkyl, etc.; R 2 is a hydrogen atom, etc.; R 3 is independently a hydrogen atom, a C 1-6 alkyl, etc., or two R 3 's, taken together, form a bridge such as methylene, etc.; R 4a and R 4b are independently a hydrogen atom, a C 1-6 alkyl, etc.; Z is a bicyclic aromatic hetero ring, etc.; Ar is a benzene ring, etc.; m1 and m2 are independently 0, 1 or 2; n is an integer of from 1 to 4. The compound and its salt act as a melanin concentrating hormone receptor antagonist, and are useful as a preventive or remedy for central system disorders, cardiovascular disorders, metabolic disorders, etc.
    本发明公开了一种化合物及其药学上可接受的盐,其化学式为(I): 其中,Q是CH或N;R1a,R1b,R1c和R1d独立地表示C1-6烷基,卤代C1-6烷基等;R2是氢原子等;R3独立地表示氢原子,C1-6烷基等,或者两个R3共同形成例如亚甲基等的桥;R4a和R4b独立地表示氢原子,C1-6烷基等;Z是双环芳香杂环,等;Ar是苯环等;m1和m2独立地表示0、1或2;n是1至4的整数。该化合物及其盐作为黑色素浓集激素受体拮抗剂,可用于预防或治疗中枢系统疾病、心血管疾病、代谢性疾病等。
查看更多